The AdvisorShares Pure US Cannabis ETF (MSOS) is trading at its highest levels of 2026, and the timing is not an accident. Investors are positioning ahead of a June 29 DEA administrative hearing that
Dea
A federally compliant cannabinoid drug developer says the DEA excluded it from the one hearing where its evidence mattered most, then watched the agency's own scientist testify to the very gap it